Monday, March 2, 2026

COVID-19 drug to reach Odisha capital shortly

Continue reading

June 26, 2020
Odisha Latest

Bhubaneswar: Hyderabad-based Hetero Healthcare Ltd's Covifor, the generic version of COVID-19 drug Remdesivir, will be available in Odisha capital soon for Rs 5,400 per 100 mg vial.

The company will supply the second lot of the drug to Kolkata, Indore, Bhopal, Lucknow, Patna, Bhubaneswar, Ranchi, Vijayawada, Cochin, Trivandrum and Goa within a week, it said. It has fixed a maximum retail price of Rs 5,400 per vial for the drug.

The drug is available in 100 mg vials (injectable). It needs to be administered intravenously in a hospital, critical care setting, under the supervision of a registered medical practitioner, the company said in a statement.

Pharma major Cipla has also said it will price its generic version of Remdesivir at less than Rs 5,000 per vial.

Also read- Glenmark Launches COVID-19 Drug After DCGI Nod; MRP At Rs 103 Per Tablet.

About the Author
Sambad English Bureau

Sambad English covers latest news and happenings from Odisha from the house of Sambad Group, Eastern Media Limited.

728x90 Advertisement

You May Also Like


DISCLAIMER
All content on this website is the exclusive property of Eastern Media Limited. Any downloadable material, including but not limited to electronic or digital versions of the newspaper (e-paper) in any format, is provided solely for personal use. Unauthorized dissemination, distribution, circulation, or publication of any content or e-paper (whether in PDF or other formats) by any means, including on social media platforms, without prior authorization, permission, or license is strictly prohibited.